DALE Pharma
La BCE indique pour DALE Pharma la situation juridique 050 (Registre : faillite ouverte) ; c'est l'état actuel selon le registre lui-meme, qui ne mentionne pas de date de debut. Les comptes annuels de 2023 montrent des capitaux propres de €606k et un résultat net de €716.
| Capitaux propres | €606k |
| Résultat net | €716 |
| Effectif (ETP) | 17,6 |
| Mieux que le secteur | 52% |
Profil fragile, attention surtout à santé.
Calculé sur 4 axes sur 5. Non mesuré : croissance. Un axe non mesuré n'est pas un zéro : aucune donnée n'a été lue.
Faillite ouverte
Une procédure de faillite est déjà en cours, un score de probabilité n'a plus de sens. Consultez la chronologie d'insolvabilité pour l'état de la procédure.
Le détail complet du score, son historique par exercice et la limite de crédit indicative figurent dans Kantoor S.
Voir les plans →| Indicateur | Cette entreprise | Médiane du secteur | Position dans le secteur |
|---|---|---|---|
| Solvabilité | 19,6% | 18,0% | |
| Résultat net | €716 | €11k | |
| Capitaux propres | €606k | €80k | |
| Marge brute d'exploitation | €1,30M | €162k | |
| Frais de personnel | €1,20M | €187k |
| Exercice | 2023 |
|---|---|
| Dépôt | volledig |
| Chiffre d'affaires | €3,28M |
| EBITDA | €95k |
| Résultat net | €716 |
| Cash-flow | €51k |
| Frais de personnel | €1,20M |
| Impôts sur le résultat | - |
| Dividendes | - |
| Total actif | €3,08M |
| Capitaux propres | €606k |
| Dettes | €2,48M |
| dont ≤ 1 an | €1,75M |
| dont > 1 an | €721k |
| Fonds de roulement | €995k |
| Employés (ETP) | 17,6 |
| 2023 | |
|---|---|
| Current ratio | 1,57 |
| Quick ratio | 0,82 |
| Ratio fonds de roulement | 32,2% |
| Solvabilité | 19,6% |
| Debt / equity | 4,09 |
| Endettement à long terme | 1,19 |
| Interest coverage | 2,17 |
| Rentabilité brute | 2,8% |
| Rentabilité nette | 0,0% |
| ROA | 0,0% |
| ROE | 0,1% |
| Marge EBITDA | 2,9% |
| Crédit clients (DSO) | 151d |
| Crédit fournisseurs (DPO) | 133d |
| Rotation des stocks | 2,45 |
| Jours de stock (DSI) | 149d |
Comptes annuels complets (27 postes)
| Poste | Code | 2023 |
|---|---|---|
| Bilan, Actif | ||
| TOTAL DE L'ACTIF | 20/58 | €3,08M |
| Actifs immobilisés | 21/28 | €338k |
| Frais d'établissement | 20 | €0 |
| Immobilisations incorporelles | 21 | €192k |
| Immobilisations corporelles | 22/27 | €146k |
| Immobilisations financières | 28 | €363 |
| Actifs circulants | 29/58 | €2,75M |
| Stocks et commandes en cours | 3 | €1,30M |
| Créances à un an au plus | 40/41 | €1,41M |
| Placements de trésorerie | 50/53 | €0 |
| Valeurs disponibles | 54/58 | €34k |
| Bilan, Passif | ||
| TOTAL DU PASSIF | 10/49 | €3,08M |
| Capitaux propres | 10/15 | €606k |
| Apport / capital | 10/11 | €605k |
| Bénéfice (perte) reporté(e) | 14 | €716 |
| Dettes | 17/49 | €2,48M |
| Dettes à plus d'un an | 17 | €721k |
| Dettes à un an au plus | 42/48 | €1,75M |
| Dettes commerciales à un an au plus | 44 | €1,16M |
| Compte de résultats | ||
| Chiffre d'affaires | 70 | €3,28M |
| Marge brute d'exploitation | 9900 | €1,30M |
| Résultat d'exploitation | 9901 | €44k |
| Produits financiers | 75 | €0 |
| Charges financières | 65 | €44k |
| Résultat avant impôts | 9903 | €716 |
| Résultat de l'exercice | 9904 | €716 |
| Résultat à affecter | 9905 | €716 |
-
Emilie DewerpeAdministrateurActe Moniteur 23025753 (22-02-2023)Actif22-02-2023 → auj.
Anciens dirigeants (2)
-
Aurélie WattiezAdministrateurActe Moniteur 23025753 (22-02-2023)Ancien- → 22-02-2023
-
Liouba MuzzinAdministrateurActe Moniteur 23025753 (22-02-2023)Ancien- → 22-02-2023
| NACE primaire | Autre commerce de détail non spécialisé(47120) |
| Forme juridique | SRL(610) |
| Date de constitution | 04-10-2022 |
| Status | Actif |
| Code postal | 7850 |
Parcelles liées à cette entreprise via ses adresses BCE (siège, unités d'établissement, succursales), croisées avec le plan parcellaire cadastral. Ceci montre où l'entreprise est active, pas un registre de propriété.
| Parcelle (capakey) | Région | Superficie | Bâtiments | Hauteur / ét. |
|---|---|---|---|---|
| 55010D0046/00H000 | Wallonie | 239 m² | 1 · 118 m² | - |
| 92007F0104/00H002 | Wallonie | 229 m² | 1 · 67 m² | 13,8 m · 4 ét. |
Une seule chronologie de tout ce qui est arrivé à cette entreprise, publications, événements d'insolvabilité et de cycle de vie, changements administratifs et comptes annuels déposés.
Nous connaissons 7 actes du Moniteur belge pour cette entreprise. Aucun n'a encore été lu : ce qui s'y trouve n'a ici été ni constaté ni réfuté.
12-09-2024 Transfert du siège social de Chapelle-lez-Herlalmont à Enghien
- Rue Joseph Francq 1 boîte 4-7160 Chapelle-lez-Herlalmont - Belgique → THE MUG ENGHIEN - Grand-Place 50 -7850 Enghien
Détails techniques
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "siege_social",
"new_address": {
"raw": "THE MUG ENGHIEN - Grand-Place 50 -7850 Enghien",
"city": "Enghien",
"region": "waals_gewest",
"street": "Grand-Place",
"country": "BE",
"postcode": "7850",
"box_number": null,
"street_number": "50",
"locality_suffix": null
},
"old_address": {
"raw": "Rue Joseph Francq 1 bo\u00EEte 4-7160 Chapelle-lez-Herlalmont - Belgique",
"city": "Chapelle-lez-Herlalmont",
"region": "waals_gewest",
"street": "Rue Joseph Francq",
"country": "BE",
"postcode": "7160",
"box_number": "4",
"street_number": "1",
"locality_suffix": null
},
"effective_date": "2024-07-01",
"evidence_quote": "L\u0027assembl\u00E9e accepte \u00E0 l\u0027unanimit\u00E9 le transfert du si\u00E8ge social vers l\u0027adresse THE MUG ENGHIEN - Grand-Place 50 -7850 Enghien, en date du 01/07/2024.",
"region_changed": false,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "absolute",
"statutaire_vs_werkelijke": null,
"linguistic_region_changed": false,
"court_jurisdiction_changed": false,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2024-09-12",
"filing_date": "2024-09-03",
"act_kind_objet": "Transfert de si\u00E8ge"
},
"decision": {
"body": "assembl\u00E9e g\u00E9n\u00E9rale extraordinaire",
"date": "2024-06-20",
"unanimous": true
},
"subject_company": {
"kbo": "0791.839.803",
"name_full": "DALE Pharma",
"legal_form": "SRL",
"_kbo_filled_from_list": true
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "Didier P\u00EAtre",
"org_rep_person_name": null,
"person_role_at_subject": "Administrateur"
},
"co_filed_documents": [
"Mod DOC 19.01"
]
}01-08-2023 Augmentation de capital de 300.750 € à 300.750 €
- €0 → €300.750
Détails techniques
{
"events": [
{
"kind": "capital_increase",
"after_eur": 300750.0,
"delta_eur": 300750.0,
"before_eur": 0.0,
"_arith_derived": "before",
"share_emission": {
"agio_eur": null,
"share_form": "nominal",
"share_class": null,
"n_new_shares": 250,
"with_new_shares": true,
"nominal_value_eur": null,
"issue_price_per_share_eur": 1203.0
},
"decrease_purpose": null,
"contribution_type": "numeraire",
"paid_up_delta_eur": 300750.0,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": "create"
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
},
{
"kind": "share_class_creation",
"after_eur": null,
"delta_eur": null,
"before_eur": null,
"share_emission": {
"agio_eur": null,
"share_form": null,
"share_class": null,
"n_new_shares": null,
"with_new_shares": false,
"nominal_value_eur": null,
"issue_price_per_share_eur": null
},
"decrease_purpose": null,
"contribution_type": null,
"paid_up_delta_eur": null,
"n_shares_destroyed": null,
"not_yet_called_eur": null,
"merger_new_shares_n": null,
"merger_exchange_ratio": null,
"distribution_amount_eur": null,
"statutory_unavailable_equity_op": null
}
],
"notary": {
"name": "Peter VAN MELKEBEKE",
"firm_city": null,
"firm_name": "BERQUIN NOTAIRES",
"office_city": "Bruxelles",
"is_associated": true
},
"act_meta": {
"language": "fr",
"pub_date": "2023-08-01",
"filing_date": "2023-07-28",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "assembl\u00E9e_generale_extraordinaire",
"act_date": "2023-07-25",
"unanimous": null,
"under_authorized_capital": false,
"underlying_resolution_date": null
},
"bedrijfsrevisor": {
"waived": true,
"firm_kbo": null,
"firm_name": null,
"ibr_number": null,
"mission_type": null,
"individual_name": null
},
"subject_company": {
"kbo": "0791.839.803",
"name_full": "DALE Pharma",
"legal_form": "Soci\u00E9t\u00E9 \u00E0 responsabilit\u00E9 limit\u00E9e",
"is_foreign_registered": false
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [
"exp\u00E9dition du proc\u00E8s-verbal",
"procuration",
"texte coordonn\u00E9 des statuts"
],
"shareholders_after": [],
"share_classes_after": []
}14-03-2023 Transfert du siège social de Bruxelles à Piéton
- Boulevard de l'Empereur 10-1000 Bruxelles - Belgique → rue Joseph Francq 1 boite 4 à 7160 Piéton
Détails techniques
{
"events": [
{
"kind": "zetel_transfer",
"seat_type": "combined",
"new_address": {
"raw": "rue Joseph Francq 1 boite 4 \u00E0 7160 Pi\u00E9ton",
"city": "Pi\u00E9ton",
"region": "waals_gewest",
"street": "rue Joseph Francq",
"country": "BE",
"postcode": "7160",
"box_number": "4",
"street_number": null,
"locality_suffix": null
},
"old_address": {
"raw": "Boulevard de l\u0027Empereur 10-1000 Bruxelles - Belgique",
"city": "Bruxelles",
"region": "brussels_hoofdstedelijk_gewest",
"street": "Boulevard de l\u0027Empereur",
"country": "BE",
"postcode": "1000",
"box_number": null,
"street_number": "10",
"locality_suffix": null
},
"effective_date": "2022-12-01",
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale propose de modifier le si\u00E8ge de la soci\u00E9t\u00E9 situ\u00E9 actuellement sis boulevard de l\u0027empereur 10 \u00E0 1000 Bruxelles vers le si\u00E8ge d\u0027exploitation situ\u00E9e sis rue Joseph Francq 1 boite 4 \u00E0 7160 Pi\u00E9ton.",
"region_changed": true,
"is_statute_change": true,
"nationality_change": false,
"old_address_source": "header_volledig_adres",
"statute_clause_text": null,
"statute_article_number": null,
"effective_date_qualifier": "absolute",
"statutaire_vs_werkelijke": "statutaire",
"linguistic_region_changed": false,
"court_jurisdiction_changed": true,
"effective_date_is_approximate": false
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": null,
"filing_date": "2023-03-06",
"act_kind_objet": "Objet de l\u0027acte:"
},
"decision": {
"body": "algemene_vergadering",
"date": null,
"unanimous": true
},
"subject_company": {
"kbo": "0791.839.803",
"name_full": "DALE Pharma",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "person",
"org_kbo": null,
"org_name": null,
"person_name": "DIDIER P\u00CATRE",
"org_rep_person_name": null,
"person_role_at_subject": "Administrateur"
},
"co_filed_documents": [
"Copie \u00E0 publier aux annexes au Moniteur belge apr\u00E8s d\u00E9p\u00F4t de l\u0027acte au greffe"
]
}22-02-2023 1 administrateur nommé, 2 démissionnaires
- Emilie Dewerpe, Bestuurder
- Aurélie Wattiez, Bestuurder
- Liouba Muzzin, Bestuurder
Détails techniques
{
"events": [
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Aur\u00E9lie Wattiez",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale valide les d\u00E9missions de Aur\u00E9lie Wattiez et Liouba Muzzin er\u0131 tant qu\u0027administrateur de",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_out",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Liouba Muzzin",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale valide les d\u00E9missions de Aur\u00E9lie Wattiez et Liouba Muzzin er\u0131 tant qu\u0027administrateur de",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "director_in",
"role": "bestuurder",
"person": {
"rrn": null,
"name": "Emilie Dewerpe",
"address": "rue de la concorde 68 \u00E0 7100 La Louvi\u00E8re",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Emilie Dewerpe domicili\u00E9e rue de la concorde 68 \u00E0 7100 La Louvi\u00E8re est propos\u00E9e comme administrateur",
"decharge_status": null,
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": "immediate"
},
{
"kind": "decharge_granted",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Aur\u00E9lie Wattiez",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale valide les d\u00E9missions de Aur\u00E9lie Wattiez et Liouba Muzzin er\u0131 tant qu\u0027administrateur de",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Liouba Muzzin",
"address": null,
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "L\u0027assembl\u00E9e g\u00E9n\u00E9rale valide les d\u00E9missions de Aur\u00E9lie Wattiez et Liouba Muzzin er\u0131 tant qu\u0027administrateur de",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
},
{
"kind": "decharge_granted",
"role": "commissaris",
"person": {
"rrn": null,
"name": "Emilie Dewerpe",
"address": "rue de la concorde 68 \u00E0 7100 La Louvi\u00E8re",
"birth_date": null,
"profession": null,
"birth_place": null
},
"reason": null,
"subkind": null,
"via_org": null,
"statutory": null,
"compensated": null,
"effective_date": null,
"evidence_quote": "Emilie Dewerpe domicili\u00E9e rue de la concorde 68 \u00E0 7100 La Louvi\u00E8re est propos\u00E9e comme administrateur",
"decharge_status": "granted",
"mandate_duration": null,
"rep_rotation_new_rep": null,
"rep_rotation_old_rep": null,
"effective_date_qualifier": null
}
],
"notary": {
"name": null,
"firm_city": null,
"firm_name": null,
"office_city": null,
"is_associated": false
},
"act_meta": {
"language": "fr",
"pub_date": "2023-02-22",
"filing_date": null,
"act_kind_objet": "Objet de l\u0027acte:"
},
"decisions": [
{
"body": "algemene_vergadering",
"date": "2023-02-13",
"unanimous": true
},
{
"body": "algemene_vergadering",
"date": "2023-02-13",
"unanimous": true
}
],
"is_correction": false,
"subject_company": {
"kbo": "0791.839.803",
"name_full": "DALE Pharma",
"legal_form": "SRL"
},
"publication_proxy": {
"kind": "none",
"org_kbo": null,
"org_name": null,
"person_name": null,
"org_rep_person_name": null,
"person_role_at_subject": null
},
"co_filed_documents": [],
"corrected_publication_numac": null
}| Dénomination légaleFR | DALE Pharma |